3Hanania NA,Kalberg C,Yates J. The bronchodilator response to sal meterol is maintained with regular long termuse in patients with COPD[J]. Pulmonary Phamacol, 2005, (1) : 19-22.
5Scow DT, Luttermoser GK, Dickerson KS. Leukotriene inhibitors in the treatment of allergy and asthma [J].Am Faro Physidan, 2007,75 (1) :65-70.
6Straub DA, Minocchieri S, Moeller A. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old[J].Chest, 2005,2 : 509-514.
7Prussin C, Griffith DT, Boesel KM, et al. Omalizumab treatment downregulates dendritic cell Fcepsilon RI expression[J]. Allerg Clin Immunol,2003,112(6):1 147-1 154.
8Yoshihara S, Kanno N, Yamada Y, et al, Effects of early intervention with inhaled sodium eromoglycate in childhood asthma[J].Lung, 2006,184:63-72.
9Duan W, Chan J H, Mckay K, et al. Inhaled p38alpha mitogenactivated protein kinase antisense oligonucleotide attenuates asthma in mice[J]. Am J Respir Crit Care Med,2005,171(6):571-578.
4Torphy TJ. Phosphodiestease isozymes; Molecular targets for novel anti-asthma agents. Am J Respir Crit Care Med 1998;157:35170.
5Torphy TJ, Barnette MS, Underwood DC, et al. Ariflo (SB 207499), a second generation Phosphodiestease 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulm Pharmacol Ther 1999 - 12 : 131 - 35.
6Manning CD, Burman M, Christensen SB, et al. Suppresion of human inflamma-tory cell functionby subtype selective PDE-4 inhibitors correlates with inhibition of PDE4A and PDE4B. Br J Clin Pharmcol ; 128:1393 -98.
7Hatzelmann A,Schudt C. Anti-inflammatory and imnmnomodulatory potential of the novel PDE-4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther 2001, 297 : 267- 79.
8Wollin N, Bundschuh DS, Ostermann A, et al. Inhibition of asthma key medlar-ors and inflammation by roflumilast:effects on the time course in ovalbumin challenged brown Norway rats.Am J Respir Crit Care Med 2004; 169:A803(abstr).
9Boswell-Smith V, Spina D, Page CP. Regulation by selective Phosphodieste-ase 4 isoenzyme inhibitor of non-adrenergic,non cholinergic contract on guinea pig isolated main bronchus. Am J Respir Crit Care Med 2004; 169:A180(abstr).
10Zussman BD,Benincosa LJ,Webber DM0e(al. An overview of the pharmaco-kinetics of cilomilast (Ariflo), a new , Orally active Phosphodiestease 4 inhibitor, in healthy young and elderly volunteers. J Clin Pharmacol 2001 , 41 : 950- 98.
4Chung KF,Wenzel SE,Brozer JL,et al.International ERS/ATS guidelines ondefinition,evaluation and treatment of severe asthma[J].Eur Respir J,2014,44(1):267.
